Integrin Targeting Systems for Tumor Diagnosis and Therapy /
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
New York, NY :
Springer New York : Imprint: Humana,
2018.
|
| Edition: | 1st ed. 2018. |
| Series: | Methods in Pharmacology and Toxicology,
|
| Subjects: |
Table of Contents:
- Tumor Targeting by RGD-Grafted PLGA-Based Nanotheranostics Loaded with Paclitaxel and Superparamagnetic Iron Oxides
- Fabrication of cRGD Conjugated Dual Responsive Micelles to Target αvβ5 Integrin Overexpressed Cancer.- Copper-Free Click Chemistry Modification of Nanovectors for Integrin Targeted Cancer Therapy.- Preparation, Characterization, and In Vitro and In Vivo Evaluation of PEGylated Liposomal Doxorubicin Modified with Different cRGD Peptides
- Preparation of Heterobivalent and Multivalent Radiopharmarmaceuticals to Target Tumors Over-Expressing Integrins.- 177Lu Labeled RGD-BBN Peptide for Targeting Prostate Cancer
- Integrin-Mediated Targeting of Liposomally-Bound siRNAs to Tumor Vasculatures
- Integrin αvβ3-Targeted Optical Imaging with Metal Oxide Nanomaterials: Focusing on Zinc Oxide
- Integrin Targeting Using RGD-Based Peptide Amphiphiles
- Cyclic-RGDfK-Directed Docetaxel Loaded Nanomicelles for Angiogenic Tumor Targeting
- Targeting Glioma Cancer Cells with Fluorescent Nanodiamonds Via Integrin Receptors.- NIR Imaging-Guided Photothermal Therapy by cRGD-Conjugated Solid Lipid Nanoparticles Encapsulating IR-780
- Synergistic Active Targeting to B16F10 Tumors by αvβ3/CD44-Targeted Nanoparticles Loaded with Docetaxel.